Vicki Seyfert-Margolis, Ph.D. former senior advisor for Science Innovation and Policy at the U.S Food and Drug Administration says trying to cure every orphan disease would consume the entire U.S. GDP. How can we lower drug and device development costs?
Just as a ship’s captain needs to prepare her ship and crew for any possible weather, leaders in academic medicine needs to prepare our organizations for an uncertain future.
David Jackson, senior vice president of strategic services, ARUP Laboratories, says more companies are looking for alternative ways to lower insurance premiums. Could on-site clinics be the answer?
Michael Glenn, M.D., chief medical officer, and Lucy Glenn, M.D., chief of radiology, from Virginia Mason share what's working for them.
Transforming academic medicine is a complex task, it requires that we rethink the entire structure - governance, money flows, teams vs. individuals, the list is long. Perhaps the biggest challenge, however, is how to take the leadership vision and engaging the entire institution in acting on the vision.
Scott Plutchak, Ph.D., Interm Director the edge of Chaos Innowatch Center, University of Alabama at Birmingham, shares his thoughts.
Martin Kohn, M.D., recently gave a presentation at the University of Utah Health Sciences.
Paula Termuhlen, M.D., general surgery residency program director, Medical College of Wisconsin, says residency programs need to be reimagined in order to face the physician deficit head-on.